Trinity Legacy Partners LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Trinity Legacy Partners LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,273 shares of the healthcare conglomerate’s stock after purchasing an additional 163 shares during the quarter. UnitedHealth Group accounts for approximately 1.5% of Trinity Legacy Partners LLC’s holdings, making the stock its 22nd biggest position. Trinity Legacy Partners LLC’s holdings in UnitedHealth Group were worth $5,232,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of UNH. Macroview Investment Management LLC increased its stake in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the period. Delos Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares in the last quarter. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC boosted its position in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $575.59 on Wednesday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $531.51 billion, a PE ratio of 35.18, a price-to-earnings-growth ratio of 1.60 and a beta of 0.58. The business’s 50-day moving average price is $578.80 and its 200 day moving average price is $522.51. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.14 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analysts Set New Price Targets

Several analysts recently commented on UNH shares. Argus raised their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. HSBC upped their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Truist Financial boosted their target price on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. TD Cowen lifted their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Robert W. Baird raised their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.